HIV-associated gut dysbiosis drives oncogenesis through metabolic-immune crosstalk: mechanisms and therapeutic implications
HIV-induced gut microbiota dysbiosis perpetuates mucosal barrier disruption and systemic inflammation despite antiretroviral therapy (ART), creating a tumor-permissive microenvironment. This review synthesizes evidence linking HIV-associated microbial alterations to oncogenesis through three converg...
Saved in:
| Main Authors: | Qingquan Meng, Liran Xu, Furong Xu, Xiaohan Shen, Jingyu Yue |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-08-01
|
| Series: | Frontiers in Oncology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2025.1634388/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The role of gut microbiota dysbiosis in the inflammatory pathogenesis of diabetic retinopathy
by: Liqing Xie, et al.
Published: (2025-07-01) -
Crosstalk between Gut Microbiota Metabolites and Ischemic Stroke
by: TANG Qiang
Published: (2022-10-01) -
From bench to bed: deep insights the tacrolimus-induced diabetes and gut microbiota dysbiosis
by: Yuting Han, et al.
Published: (2025-08-01) -
Gut microbiota dysbiosis in people living with HIV who have cancer: novel insights and diagnostic potential
by: Zhiman Xie, et al.
Published: (2025-08-01) -
Gut dysbiosis impairs hippocampal plasticity and behaviors by remodeling serum metabolome
by: Guoqiang Liu, et al.
Published: (2022-12-01)